These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 17101549)
1. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis. Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549 [TBL] [Abstract][Full Text] [Related]
2. Tetranectin in cerebrospinal fluid: biochemical characterisation and evidence of intrathecal synthesis or selective uptake into CSF. Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M Clin Chim Acta; 2005 Sep; 359(1-2):65-71. PubMed ID: 15901484 [TBL] [Abstract][Full Text] [Related]
3. Tetranectin is a potential biomarker in cerebrospinal fluid and serum of patients with epilepsy. Wang L; Pan Y; Chen D; Xiao Z; Xi Z; Xiao F; Wang X Clin Chim Acta; 2010 Apr; 411(7-8):581-3. PubMed ID: 20102706 [TBL] [Abstract][Full Text] [Related]
4. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis]. Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427 [TBL] [Abstract][Full Text] [Related]
5. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662 [TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases. Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965 [TBL] [Abstract][Full Text] [Related]
7. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis. Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029 [TBL] [Abstract][Full Text] [Related]
8. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis. Chowdhury SA; Lin J; Sadiq SA Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193 [TBL] [Abstract][Full Text] [Related]
9. [Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis]. Caudie C; Birouk AM; Bancel J; Claudy D; Gignoux L; Vukusic S; Confavreux C Pathol Biol (Paris); 2005 Mar; 53(2):68-74. PubMed ID: 15708649 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Gelman BB; Rifai N; Christenson RH; Silverman LM Ann Clin Lab Sci; 1988; 18(1):46-52. PubMed ID: 3355096 [TBL] [Abstract][Full Text] [Related]
11. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. Bartosik-Psujek H; Archelos JJ J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285 [TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders. Kittur SD; Kittur DS; Soncrant TT; Rapoport SI; Tourtellotte WW; Nagel JE; Adler WH Ann Neurol; 1990 Aug; 28(2):168-73. PubMed ID: 2221845 [TBL] [Abstract][Full Text] [Related]
13. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Gieffers J; Pohl D; Treib J; Dittmann R; Stephan C; Klotz K; Hanefeld F; Solbach W; Haass A; Maass M Ann Neurol; 2001 May; 49(5):585-9. PubMed ID: 11357948 [TBL] [Abstract][Full Text] [Related]
14. [Neurofilament protein light in multiple sclerosis]. Zhang Y; Li X; Qiao J Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263 [TBL] [Abstract][Full Text] [Related]
15. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. Link H; Huang YM J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide as an activity marker in multiple sclerosis. Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739 [TBL] [Abstract][Full Text] [Related]
17. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413 [TBL] [Abstract][Full Text] [Related]
18. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica. Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal origin of CSF ribonuclease. Differences between infectious processes of the nervous system and multiple sclerosis. Allinquant B; Musenger C; Schuller E Acta Neurol Scand; 1984 Jul; 70(1):12-9. PubMed ID: 6206680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]